Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China

Figures & data

Figure 1 Numbers of ADE reports submitted by SAHZU to China’s SRS and proportion of “new” and “serious” ADE reports.

Notes: Proportion of “new” and “serious” ADE reports (%). *P<0.05 (compared with data of 2012).
Abbreviations: ADE, adverse drug event; SAHZU, the Second Affiliated Hospital of Zhejiang University; SRS, spontaneous reporting system.

Figure 2 Proportions of “new” and “serious” ADE reports and “serious” ADE reports submitted by SAHZU to China’s SRS and the proportion of reports submitted by pharmacists during 2012–2017.

Notes: Proportion of reports submitted by clinical pharmacists (%), *P<0.05 (compared with data of 2013). Proportions of “new” and “serious” ADE reports and “serious” ADE reports submitted by SAHZU to China’s SRS (%), ^#P<0.05 (compared with data of 2012).
Abbreviations: ADE, adverse drug event; SAHZU, the Second Affiliated Hospital of Zhejiang University; SRS, spontaneous reporting system.

Figure 3 ADE source distribution reported by clinical pharmacists in 2017.

Abbreviation: ADE, adverse drug event.